ClassID:

20212

A61K31/12 - page 7 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients Ketones

Recent Application in this class:
#1801
20090325963
2009-12-31

Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease

#1802
20090325915
2009-12-31

Crystalline levosalbutamol sulphate and polymorphic forms thereof

#1803
20090318565
2009-12-24

Novel Compositions for the Enhancement of the Anti-oxidant Potential of Hydrogenated Curcuminoids or Combinations Thereof

#1804
20090304827
2009-12-10

Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects

#1805
20090298944
2009-12-03

Pharmaceutical composition

#1806
20090297644
2009-12-03

Herbal compositions for the treatment of diseases of the oral cavity

#1807
20090291924
2009-11-26

Drug design for tubulin inhibitors, compositions, and methods of treatment thereof

#1808
20090291102
2009-11-26

Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof

#1809
20090286884
2009-11-19

Hops Beta-Acid Anti-Diabetic Composition

#1810
20090285905
2009-11-19

Systems and processes for spray drying hydrophobic and hydrophilic components

#1811
20090285865
2009-11-19

Palatable, solid oral formulations for male chemical sterilization

#1812
20090285864
2009-11-19

Therapeutic formulation

#1813
20090282496
2009-11-12

Androgen Receptor Related Methods for Treating Bladder Cancer

#1814
20090280483
2009-11-12

Methods for Screening Interleukin-6 (IL-6) Signal Transduction Inhibitors

#1815
20090275554
2009-11-05

Aminocarboxylic acid derivative and medicinal use thereof

#1816
20090274778
2009-11-05

Compositions Exhibiting Inhibition Of Cyclooxygenase-2

#1817
20090263522
2009-10-22

Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2

#1818
20090263492
2009-10-22

Diagnostic Methods and Genetic Markers for Alzheimer Disease

#1819
20090247522
2009-10-01

Hsp90 family protein inhibitors

#1820
20090239944
2009-09-24

Novel Use of Organic Compounds

#1821
20090239943
2009-09-24

Nutraceutical composition and methods for its use

#1822
20090234019
2009-09-17

T type calcium channel inhibitors

#1823
20090232909
2009-09-17

Method for determining physiological effects of hemoglobin

#1824
20090221694
2009-09-03

Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone

#1825
20090220624
2009-09-03

Compositions comprising apocynin, ginkgo and ginger and uses thereof

#1826
20090215886
2009-08-27

Anti-inflammatory formulation

#1827
20090215145
2009-08-27

METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE

#1828
20090209607
2009-08-20

Inhibitors of Akt activity

#1829
20090208493
2009-08-20

Compounds and methods for the selective inhibition of ABCB1, ABCC1 and ABCG2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput flow cytometry assay to detect selective inhibitors

#1830
20090208434
2009-08-20

3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use in cosmetic and pharmaceutical preparations

#1831
20090203653
2009-08-13

Compositions and methods using apocynin compounds and nitric oxide donors

#1832
20090192122
2009-07-30

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#1833
20090191287
2009-07-30

Mitigation of Inflammation-Related Injuries

#1834
20090175869
2009-07-09

Pulsatile Dosing of Gossypol for Treatment of Disease

#1835
20090163570
2009-06-25

BLADDER CANCER TREATMENT AND METHODS

#1836
20090162299
2009-06-25

Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer

#1837
20090156637
2009-06-18

BUTYROPHENONES AND SIGMA-1 RECEPTOR ANTAGONISTS PROTECT AGAINST OXIDATIVE-STRESS

#1838
20090143433
2009-06-04

COCKTAIL FOR MODULATION OF ALZHEIMER'S DISEASE

#1839
20090131373
2009-05-21

Phospholipid complexes of curcumin having improved bioavailability

#1840
20090124561
2009-05-14

Dihydroxyphenyl compounds and glucoside compounds thereof

#1841
20090123904
2009-05-14

Method for preserving cells, tissues or organs using a solution comprising alkyldiamine-beta-cyclodextrin

#1842
20090111893
2009-04-30

Method of lowering blood glucose and method of treating diabetes and obesity

#1843
20090110735
2009-04-30

Controlled release formulations

#1844
20090099211
2009-04-16

TREATMENTS FOR CONGESTIVE HEART FAILURE

#1845
20090098226
2009-04-16

COMPOSITION FOR COSMETIC OR PHARMACEUTICAL-DERMATOLOGICAL USE

#1846
20090093545
2009-04-09

Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis

#1847
20090087385
2009-04-02

Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease

#1848
20090076108
2009-03-19

METHOD FOR TREATING OBESITY

#1849
20090075957
2009-03-19

Xanthohumol compositions and methods of using same

#1850
20090075948
2009-03-19

COMPOSITIONS AND METHODS FOR REGULATING CELLULAR PROTECTION

#1851
20090075908
2009-03-19

Agent for strengthening calcium containing tissue and use thereof

#1852
20090075888
2009-03-19

Cardiovascular and Brain Cell Therapy Using Intracellular Ryanodine Receptor Modulation by the Estrogen Receptor Beta

#1853
20090074884
2009-03-19

PFKB3 inhibitor for the treatment of a proliferative cancer

#1854
20090062402
2009-03-05

ACTIVE SUBSTANCE COMBINATION OF LICOCHALCONE A AND PHENOXYETHANOL

#1855
20090054530
2009-02-26

Methods and compositions that enhance bioavailability of coenzyme-Q10

#1856
20090053209
2009-02-26

Blockade of Pin1 Prevents Cytokine Production by Activated Immune Cells

#1857
20090048246
2009-02-19

Compounds and compositions for reducing lipid levels

#1858
20090047371
2009-02-19

PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND RESVERATROL AND USES THEREOF IN MEDICAL FIELD

#1859
20090042995
2009-02-12

Therapeutic formulation

#1860
20090042883
2009-02-12

ANTITUMOR AGENT

#1861
20090041687
2009-02-12

Use of opioid receptor antagonists

#1862
20090036519
2009-02-05

Peroxisome proliferator activated receptor ligand and process for producing the same

#1863
20090035379
2009-02-05

Fenofibrate compositions

#1864
20090035362
2009-02-05

Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss

#1865
20090035353
2009-02-05

NON-ABSORBENT ARTICLES CONTAINING ADDITIVES

#1866
20090029944
2009-01-29

METHODS FOR ADDING FATTY ACIDS TO AGENTS IN AQUEOUS SOLUTION TO IMPROVE BIOAVAILABILITY

#1867
20090028963
2009-01-29

Polyphenol coxib combinations and methods

#1868
20090018209
2009-01-15

CURCUMIN AND CURCUMINOID INHIBITION OF ANGIOGENESIS

#1869
20090012177
2009-01-08

Treatment of psychiatric disorders using entacapone, tolcapone and other COMT inhibitor or MB-COMT inhibitor drugs

#1870
20090012107
2009-01-08

Antiviral compounds and methods of using thereof

#1871
20090011059
2009-01-08

Ginger Extract For Inhibiting Human Drug Transporters

#1872
20080318956
2008-12-25

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#1873
20080317840
2008-12-25

Compositions and methods for polymer-caged liposomes

#1874
20080317727
2008-12-25

Method of skin treatment for rosacea using epidermal growth factor

#1875
20080312335
2008-12-18

Liver protection compounds of the cyclohexenone type from

#1876
20080312333
2008-12-18

Agent for Preventing/Ameliorating Life Style-Related Diseases Containing Turmeric Essential Oil Component

#1877
20080312186
2008-12-18

Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions

#1878
20080300304
2008-12-04

Ginger Fraction For Inhibiting Human Cyp Enzymes

#1879
20080287528
2008-11-20

Therapeutic methods and compositions involving isoflavones

#1880
20080280826
2008-11-13

Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway

#1881
20080279940
2008-11-13

Microemulsions of Cannabinoid Receptor Binding Compounds

#1882
20080275100
2008-11-06

Propofol analogs, process for their preparation, and methods of use

#1883
20080254141
2008-10-16

Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use

#1884
20080254056
2008-10-16

Green Alga Extract with High Astaxanthin Content and Method of Producing the Same

#1885
20080253961
2008-10-16

Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics

#1886
20080249071
2008-10-09

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#1887
20080248131
2008-10-09

Protein Kinase Modulation by Hops and Acacia Products

#1888
20080226755
2008-09-18

Composition to enhance the bioavailability of curcumin

#1889
20080221115
2008-09-11

Use of long-chain alcohol derivatives for the treatment of alopecia areata

#1890
20080207553
2008-08-28

Biodegradable cationic polymers

#1891
20080200558
2008-08-21

Inhibitory or blocking agents of molecular generating and/or inducing functions

#1892
20080200424
2008-08-21

Preparation for Treating Cancer

#1893
20080188475
2008-08-07

Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators

#1894
20080182900
2008-07-31

Method of treatment of virus infections using shikonin compounds

#1895
20080160116
2008-07-03

Compositions and Methods Comprising Zingiber Species

#1896
20080160007
2008-07-03

Diagnosis and treatment of cancer related to human dormancy

#1897
20080152707
2008-06-26

Solubilized CoQ-10 and carnitine

#1898
20080145449
2008-06-19

Thiol reactive agents as a therapeutic modality

#1899
20080139827
2008-06-12

Method for improving the shelf-life of hematoxylin staining solutions

#1900
20080139496
2008-06-12

COMBINATION THERAPY FOR REDUCTION OF TOXICITY OF CHEMOTHERAPEUTIC AGENTS

#1901
20080138400
2008-06-12

Liposomal curcumin for treatment of diseases

#1902
20080132568
2008-06-05

COMPOUNDS WITH ANTI-ANDROGENIC ACTIVITY AND THE USE THEREOF

#1903
20080124412
2008-05-29

Methods for reducing circulating glucose levels

#1904
20080114066
2008-05-15

Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function

#1905
20080103328
2008-05-01

Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators

#1906
20080103213
2008-05-01

LIPOSOMAL CURCUMIN FOR TREATMENT OF NEUROFIBROMATOSIS

#1907
20080103103
2008-05-01

Reagents and methods to treat ocular diseases and infection

#1908
20080096850
2008-04-24

METHODS FOR INHIBITING THE PRODUCTION OF TSST-1

#1909
20080085932
2008-04-10

Pharmaceutical compositions useful in prevention and treatment of Beta-amyloid protein-induced disease

#1910
20080076821
2008-03-27

INTRANASALLY ADMINISTERING CURCUMIN PRODRUGS TO THE BRAIN TO TREAT ALZHEIMER'S DISEASE

#1911
20080076737
2008-03-27

Drug design for tubulin inhibitors, compositions, and methods of treatment thereof

#1912
20080075793
2008-03-27

ANTIVIRAL COMPOSITIONS AND METHODS OF USE

#1913
20080075671
2008-03-27

INTRANASALLY ADMINISTERING CURCUMIN TO THE BRAIN TO TREAT ALZHEIMER'S DISEASE

#1914
20080069900
2008-03-20

Combination chemotherapy compositions and methods

#1915
20080069889
2008-03-20

Compressible resilient granules and formulations prepared therefrom

#1916
20080064759
2008-03-13

Process for preparing fenofibrate compositions

#1917
20080063726
2008-03-13

Fenofibrate compositions

#1918
20080058426
2008-03-06

COMPOSITION AND METHOD FOR TREATING PSORIASIS

#1919
20080051466
2008-02-28

Isoalpha acid based protein kinase modulation cancer treatment

#1920
20080051465
2008-02-28

Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment

#1921
20080050427
2008-02-28

Analgesic combination of tramadol and meloxicam

#1922
20080050413
2008-02-28

Medical stent provided with a combination of melatonin and paclitaxel

#1923
20080045604
2008-02-21

COMPOSITION AND METHOD FOR FACILITATING THE HEALING OF NON-HEALING AND SLOW-HEALING WOUNDS AND ULCERATIONS

#1924
20080045591
2008-02-21

Chemical compounds

#1925
20080031986
2008-02-07

Protein kinase modulation by hops and acacia products

#1926
20080026983
2008-01-31

Compositions and methods for alleviating joint pain and improving joint flexibility

#1927
20080020998
2008-01-24

Sustained release compositions for the therapeutic management of pain, inflammation and inflammation-associated disorders and prophylactic/ therapeutic methods thereof

#1928
20080015181
2008-01-17

Pharmaceutical Compositions Comprising Droxidopa

#1929
20080008776
2008-01-10

Natural extract containing xanthohumol, and method for the production thereof products produced therefrom

#1930
20070299042
2007-12-27

USE OF ETODOLAC TO TREAT HYPERPLASIA

#1931
20070287755
2007-12-13

Orally administered compound for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin dificiency

#1932
20070281021
2007-12-06

Sustained release formulation of naltrexone

#1933
20070265316
2007-11-15

Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof

#1934
20070265191
2007-11-15

Pharmaceutical compositions and methods for peptide treatment

#1935
20070259843
2007-11-08

Methods and compositions for treatment of macular and retinal disease

#1936
20070259034
2007-11-08

Highly absorbable coenzyme Q10 composition and method of producing same

#1937
20070254962
2007-11-01

METHODS OF ADMINISTERING ANTI-INFLAMMATORY CYCLOOXYGENASE-2 SELECTIVE INHIBITORS

#1938
20070254900
2007-11-01

Treatments for Congestive Heart Failure

#1939
20070253941
2007-11-01

Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof

#1940
20070249728
2007-10-25

Synergistic Anti-Inflammatory Pharmaceutical Compositions and Methods of Use

#1941
20070248688
2007-10-25

Animal repellent composition and method

#1942
20070243273
2007-10-18

Reduction of the Deleterious Effects of Tobacco Smoking

#1943
20070238784
2007-10-11

Anthracenedione compounds

#1944
20070238782
2007-10-11

Naphthalenedione compounds for treating inflammation related disorders and microbial infection

#1945
20070232701
2007-10-04

Synergistic compositions useful as cytostatic, bacteriostatic and/or virostatic agents

#1946
20070231371
2007-10-04

Nutritional system and methods for increasing longevity

#1947
20070225315
2007-09-27

Methods of treating muscular wasting diseases using NF-κB activation inhibitors

#1948
20070225310
2007-09-27

Antiviral methods and compositions

#1949
20070225237
2007-09-27

Methods for the prevention and/or the treatment of glutamate cytotoxicity

#1950
20070225236
2007-09-27

Methods for the prevention and/or the treatment of glutamate cytotoxicity

#1951
20070225235
2007-09-27

Methods for the prevention and/or the treatment of glutamate cytotoxicity

#1952
20070212417
2007-09-13

Compressible resilient granules and formulations prepared therefrom

#1953
20070203112
2007-08-30

BLADDER CANCER TREATMENT AND METHODS

#1954
20070197665
2007-08-23

Oligomeric ketone compounds

#1955
20070196866
2007-08-23

Modulators of ion channel trpa1

#1956
20070196518
2007-08-23

Composition and Method for Mitigating a Negative Effect of Alcohol Consumption

#1957
20070196289
2007-08-23

Use Of Licochalcone A Or Of An Extract Of Licochalcone A From Radix Glycyrrhizae Inflatae Against Skin Aging

#1958
20070191490
2007-08-16

Withacnistin compounds for treatment of cancer

#1959
20070191412
2007-08-16

Analgesic combination of oxycodone and celecoxib

#1960
20070191330
2007-08-16

Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases

#1961
20070190136
2007-08-16

Process for producing fenofibrate tablets

#1962
20070190121
2007-08-16

Non-Absorbent Articles Containing Additives for Inhibiting the Production of TSST-1

#1963
20070185217
2007-08-09

Propofol analogs, process for their preparation, and methods of use

#1964
20070185213
2007-08-09

Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines

#1965
20070185188
2007-08-09

BLADDER CANCER TREATMENT AND METHODS

#1966
20070184133
2007-08-09

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#1967
20070184103
2007-08-09

Process for producing fenofibrate tablets

#1968
20070184040
2007-08-09

Compositions for delivery of coenzyme Q10

#1969
20070172532
2007-07-26

Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2

#1970
20070166418
2007-07-19

Treatment modalities for autoimmune diseases

#1971
20070160691
2007-07-12

Pharmaceutical composition for treating and preventing cancer comprising cinnamoni cortex extract and zizyphi fructus extract

#1972
20070154576
2007-07-05

Protein kinase modulation by hops and Acacia products

#1973
20070149623
2007-06-28

Therapeutic formulation

#1974
20070148263
2007-06-28

Composition to enhance the bioavailability of curcumin

#1975
20070142462
2007-06-21

Method of Treating Cancer

#1976
20070141183
2007-06-21

Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2

#1977
20070134194
2007-06-14

Use of licochalcone A against rosacea

#1978
20070122490
2007-05-31

Wound healing compound

#1979
20070111954
2007-05-17

Apparatus and method of wart treatment

#1980
20070110826
2007-05-17

Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision

#1981
20070105945
2007-05-10

Antimalarial drug containing synergistic combination of curcumin and artemisinin

#1982
20070104757
2007-05-10

LATENT REACTIVE BLOOD COMPATIBLE AGENTS

#1983
20070093457
2007-04-26

Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid

#1984
20070092578
2007-04-26

Skin rejuvinating supplement

#1985
20070082022
2007-04-12

LATENT REACTIVE BLOOD COMPATIBLE AGENTS

#1986
20070078180
2007-04-05

Methods and compositions for stabilizing an antioxidant

#1987
20070072943
2007-03-29

Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

#1988
20070066654
2007-03-22

Inhibitory or blocking agents of molecular generating and/or inducing functions

#1989
20070060644
2007-03-15

Therapeutic curcumin derivatives

#1990
20070059393
2007-03-15

Composition for inhibition or prevention of bone density

#1991
20070053985
2007-03-08

Coenzyme Q10-containing fine particle with excellent dispersibility

#1992
20070042063
2007-02-22

Protein kinase modulation by hops and products

#1993
20070037883
2007-02-15

Therapeutic compositions

#1994
20070032546
2007-02-08

Formulations comprising fenofibrate and a statin, and related methods of treatment

#1995
20070032532
2007-02-08

Hsp90 family protein inhibitors

#1996
20070027112
2007-02-01

Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions

#1997
20070026072
2007-02-01

Benzoquinones of enhanced bioavailability

#1998
20070020352
2007-01-25

Treatment modalities for autoimmune diseases

#1999
20070015735
2007-01-18

Water-dispersible carotenoids, including analogs and derivatives

#2000
20070014866
2007-01-18

Composition for improving the efficacy and reducing the side effects of omega 3 fatty acids, fish oils and cardiovascular and diabetic treatments

#2001
20070003646
2007-01-04

Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors

#2002
20060293264
2006-12-28

STAT3 decoy oligonucleotides and uses therefor

#2003
20060292253
2006-12-28

Active substance combination of licochalcone A and phenoxyethanol

#2004
20060286150
2006-12-21

Therapeutic methods and compositions involving isoflavones

#2005
20060281813
2006-12-14

Methods of treating hyperproliferative cell disorders

#2006
20060276536
2006-12-07

Cancer treatment using curcumin derivatives

#2007
20060276372
2006-12-07

Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders

#2008
20060275516
2006-12-07

Compositions and methods for the treatment of allergic rhinitis

#2009
20060275504
2006-12-07

Methods and compositions for augmenting cancer chemotherapeutic agents

#2010
20060275237
2006-12-07

Skin care compositions containing idebenone

#2011
20060275228
2006-12-07

Skin care compositions containing idebenone

#2012
20060270739
2006-11-30

Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation

#2013
20060270614
2006-11-30

Use of chalcones for the treatment of viral disorders

#2014
20060270589
2006-11-30

Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of visual disabilities

#2015
20060264531
2006-11-23

Biodegradable medical devices with enhanced mechanical strength and pharmacological functions

#2016
20060264359
2006-11-23

Blockade of Pin1 prevents cytokine production by activated immune cells

#2017
20060263452
2006-11-23

Topical composition containing essential oils

#2018
20060260010
2006-11-16

Ketocarotenoids from

#2019
20060258752
2006-11-16

Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors

#2020
20060258751
2006-11-16

Biodegradable cationic polymers

#2021
20060252832
2006-11-09

Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

#2022
20060252822
2006-11-09

Mitochrondrial permeability transition pore affinity labels and modulators

#2023
20060251690
2006-11-09

Skin enrichment using CoQ10 as the delivery system

#2024
20060247318
2006-11-02

Small molecule inhibitors of STAT3 and the uses thereof

#2025
20060246148
2006-11-02

Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use

#2026
20060241191
2006-10-26

Crystalline levosalbutamol sulphate and polymorphic forms thereof

#2027
20060235047
2006-10-19

Antibacterial compounds and uses thereof

#2028
20060233899
2006-10-19

Treatment of Human Multiple Myeloma by Curcumin

#2029
20060228403
2006-10-12

Nutritional supplements for cardiovascular health

#2030
20060222711
2006-10-05

COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX

#2031
20060222710
2006-10-05

COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX

#2032
20060217445
2006-09-28

Natural astaxanthin extract reduces dna oxidation

#2033
20060216295
2006-09-28

Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy

#2034
20060211766
2006-09-21

Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections

#2035
20060210656
2006-09-21

Synergistic Effects of Nuclear Transcription Factor NF-kB Inhibitors and Anti-Neoplastic Agents

#2036
20060204980
2006-09-14

Colorectal cancer therapies

#2037
20060199768
2006-09-07

Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens

#2038
20060198830
2006-09-07

Ubiquinone composition and a container for its convenient transport and storage

#2039
20060193933
2006-08-31

Modulation of inflammation by hops fractions and derivatives

#2040
20060189543
2006-08-24

Compositions and methods for the treatment of leukemia

#2041
20060183744
2006-08-17

Method for treating depression and/or anxiety

#2042
20060183728
2006-08-17

Combination chemotherapy compositions and methods

#2043
20060178439
2006-08-10

Crystalline form of zoledronic acid

#2044
20060178347
2006-08-10

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

#2045
20060177531
2006-08-10

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#2046
20060171995
2006-08-03

Formulation for increasing the deposition of dietary carotenoids in eggs

#2047
20060166948
2006-07-27

Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries

#2048
20060165820
2006-07-27

Herbal supplement to support weight loss

#2049
20060165671
2006-07-27

Novel nutraceutical compositions comprising epigallocatechin gallate

#2050
20060160895
2006-07-20

Anti-cancer agents

#2051
20060159727
2006-07-20

Prevention of Systemic Microbial Infection

#2052
20060154993
2006-07-13

Method for treating and preventing male infertility

#2053
20060154980
2006-07-13

IMPROVED COX-2 INHIBITORY COMPOSITIONS AND THERAPEUTIC REGIMEN

#2054
20060153782
2006-07-13

Skin photoageing and actinic damage treatment

#2055
20060153781
2006-07-13

Repair of dna mutagenic damage

#2056
20060148905
2006-07-06

Methods for treatment of beta-amyloid protein-induced ocular disease

#2057
20060148674
2006-07-06

Therapeutic composition

#2058
20060147558
2006-07-06

Remedies

#2059
20060147550
2006-07-06

Immune system enhancement and stimulation formulation

#2060
20060147515
2006-07-06

Bioactive dispersible formulation

#2061
20060141082
2006-06-29

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity

#2062
20060141081
2006-06-29

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

#2063
20060140925
2006-06-29

Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use

#2064
20060135446
2006-06-22

Composition for improving blood fluidity

#2065
20060134226
2006-06-22

Compositions useful to treat ocular neovascular diseases and macular degeneration

#2066
20060134008
2006-06-22

Compositions and methods for pulmonary conditions

#2067
20060128699
2006-06-15

Novel pharmacophore for the discovery and testing of na,k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions

#2068
20060127517
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#2069
20060127516
2006-06-15

Modulation of inflammation by hops fractions and derivatives

#2070
20060127515
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#2071
20060127514
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#2072
20060127513
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#2073
20060127512
2006-06-15

Modulation of inflammation by hops fractions and derivatives

#2074
20060127511
2006-06-15

Modulation of inflammation by hops fractions and derivatives

#2075
20060127505
2006-06-15

Anti-inflammatory formulations

#2076
20060127430
2006-06-15

Controlled-Release of Cosmetic and Pharmaceutical Agents via Osmotic Nano-Diffusion from Zeolite Cage Complexes

#2077
20060127384
2006-06-15

Coenzyme Q10 as antiapoptotic agent

#2078
20060122282
2006-06-08

METHOD FOR TREATING SKIN DISORDERS WITH XANTHOPHYLLS

#2079
20060122270
2006-06-08

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism

#2080
20060120978
2006-06-08

Dihydroxyphenyl compounds and glucoside compounds thereof

#2081
20060111435
2006-05-25

Compositions for treating obesity and insulin resistance disorders

#2082
20060110467
2006-05-25

Cancer chemotherapy

#2083
20060106099
2006-05-18

Novel inhibitors of ubiquitin isopeptidases

#2084
20060106064
2006-05-18

Butyrophenones and sigma-1 receptor antagonists protect against oxidative-stress

#2085
20060089411
2006-04-27

Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin

#2086
20060084704
2006-04-20

Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof

#2087
20060078596
2006-04-13

Treatment of muscle fatigue

#2088
20060078549
2006-04-13

Method of using coenzyme Qto treat Huntington's disease

#2089
20060078530
2006-04-13

Using high-density grapes to rejuvenate human skin

#2090
20060074108
2006-04-06

Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition

#2091
20060069042
2006-03-30

Cytochrome P450 2C9 inhibitors

#2092
20060067998
2006-03-30

Liposomal curcumin for treatment of cancer

#2093
20060058283
2006-03-16

Compositions comprising ubiquinones

#2094
20060058269
2006-03-16

Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation

#2095
20060057229
2006-03-16

External skin preparations for suppressing sebum secretion

#2096
20060052460
2006-03-09

Latent reactive blood compatible agents

#2097
20060051438
2006-03-09

Herbal medicaments for the treatment of neurocerebrovascular disorders

#2098
20060040000
2006-02-23

Dietary supplement formulation for controlling inflammation and cancer

#2099
20060039954
2006-02-23

Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages

#2100
20060035981
2006-02-16

Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment